128 related articles for article (PubMed ID: 12575357)
1. [Implantable cardioventer defibrillator in the treatment of malignant ventricular arrhythmias and its short-term follow-up].
Liu QM; Zhang Y; Zhou SH
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):179-80. PubMed ID: 12575357
[No Abstract] [Full Text] [Related]
2. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
[TBL] [Abstract][Full Text] [Related]
3. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
4. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
5. [Radiofrequency catheter ablation of ventricular tachycardia in patients with an implantable defibrillator. Long-term follow-up].
Cabrera AM; Cordero AB; Rodríguez JA; Carmona JR; de Teresa Galván E
Rev Esp Cardiol; 2005 May; 58(5):491-8. PubMed ID: 15899194
[TBL] [Abstract][Full Text] [Related]
6. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
Connolly SJ; Krahn A; Klein G
Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
[No Abstract] [Full Text] [Related]
7. [Cardiac arrhythmias (XII). The implantable automatic defibrillator as the treatment of malignant ventricular arrhythmias].
Block M; Hammel D; Martínez Rubio A; Breithardt G
Rev Esp Cardiol; 1993 Dec; 46(12):821-36. PubMed ID: 8134696
[No Abstract] [Full Text] [Related]
8. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
[TBL] [Abstract][Full Text] [Related]
9. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
Andersen M; Videbaek R; Boesgaard S; Sander K; Hansen PB; Gustafsson F
J Heart Lung Transplant; 2009 Jul; 28(7):733-5. PubMed ID: 19560703
[TBL] [Abstract][Full Text] [Related]
10. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
11. Ventricular fibrillation and life-threatening ventricular tachycardia in the setting of outflow tract arrhythmias--the place of ICD therapy.
Valk SD; Dabiri-Abkenari L; Theuns DA; Thornton AS; Res JC; Jordaens L
Int J Cardiol; 2013 May; 165(2):385-7. PubMed ID: 22989608
[No Abstract] [Full Text] [Related]
12. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
Lou ZY; Zhou MH; Li XQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
[No Abstract] [Full Text] [Related]
13. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of sudden death using implantable defibrillators].
Toivonen L; Viitasalo M; Järvinen A; Verkkala K; Nieminen MS; Heikkilä J
Duodecim; 1991; 107(16):1323-30. PubMed ID: 1365354
[No Abstract] [Full Text] [Related]
15. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
16. Ventricular tachycardia and ventricular fibrillation.
Srivathsan K; Ng DW; Mookadam F
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines for cardioverter defibrillator implantation].
Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
[No Abstract] [Full Text] [Related]
19. A comprehensive approach to management of ventricular arrhythmias.
Kusumoto F
Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
[TBL] [Abstract][Full Text] [Related]
20. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
